Heron Therapeutics, Inc. (HRTX) is a biotechnology firm headquartered in San Diego, California, focused on innovative therapies to meet critical unmet medical needs in pain management and antiemetic care. The company is engaged in the research, development, and commercialization of novel pharmaceutical products, with a particular emphasis on improving the quality of life for patients undergoing surgery and cancer treatments. With a strong pipeline of candidates and a commitment to addressing significant healthcare challenges, Heron is positioned to make impactful contributions to therapeutic areas with high demand for effective solutions.